Autoimmune Diseases and HIV
Immune system diseases get up while acquired autoimmunity improvement to pathogenic autoimmunity. Hereditary components notwithstanding ecological reasons direct this turn of events. The global commercial center length of Autoimmune Disease Therapeutics was $109,833 million of every 2017 and is anticipated to reach $153,320 million with the guide of utilizing the surrender of 2025, with a CAGR of 4.2 18-2025.
Related Conference of Autoimmune Diseases and HIV
Autoimmune Diseases and HIV Conference Speakers
Recommended Sessions
- Autoimmune Diseases and HIV
- Hematopoietic, Lymphoid Malignancies and Immune System Development
- Immune Disorder
- Immune Response Regulation
- Immune Response Regulation
- Immune System and Immunology
- Immunization and Vaccination
- Immunogenetics
- Immunoresearch and Immunotechnology
- Microbial Parasitic and Fungal Immunology
- Mucosal and local Immunology
- NeuroImmunology
- OncoImmunology
- Stem Cells Immunology
- Technological Innovations in Immunology
- Therapeutic methods to autoimmunity
- Thyroid Autoimmunity
- Transplantation and Computational Immunology
- Vaccines and Immunotherapy
- Viral Immunology
Related Journals
Are you interested in
- Adaptive Immunity, Memory Formation & T-Cell Engineering - European Immunology 2026 (France)
- Allergy, Hypersensitivity & Immune Tolerance Strategies - European Immunology 2026 (France)
- Autoimmunity Mechanisms & Precision Immunoregulation - European Immunology 2026 (France)
- Computational Immunology, AI Modeling & Immune System Simulation - European Immunology 2026 (France)
- Cytokine Signaling Networks & Immune Modulation - European Immunology 2026 (France)
- Immune Cell Reprogramming & Gene-Edited Immunotherapies - European Immunology 2026 (France)
- Immunometabolism & Cellular Energy Dynamics - European Immunology 2026 (France)
- Inflammation Biology & Chronic Immune Disorders - European Immunology 2026 (France)
- Innate Immune Sensors, Pattern Recognition & Host Defense - European Immunology 2026 (France)
- Microbiome–Immune Axis & Host Interaction Pathways - European Immunology 2026 (France)
- Mucosal Immunity & Barrier Protection Mechanisms - European Immunology 2026 (France)
- Nanotechnology-Enabled Immune Delivery Systems - European Immunology 2026 (France)
- Next-Generation Vaccines & Antigen Engineering - European Immunology 2026 (France)
- Tumor Immunology & Personalized Cancer Immunotherapies - European Immunology 2026 (France)
- Viral Immunology, Emerging Pathogens & Host Response - European Immunology 2026 (France)